Ingredient

Evogliptin Tartrate

Alogliptin Tartrate is a blood glucose control ingredient used in the treatment of type 2 diabetes.

See medicines used for Chronic Conditions
All medicines
6
Single ingredient
1
Combination
5
Prescription medication
6

MFDS ingredient code M263350

What does it do?

Alogliptin Tartrate is a diabetes medication that belongs to the DPP-4 inhibitor class. This ingredient is used to lower blood sugar by promoting insulin secretion and inhibiting blood sugar elevation.

Alogliptin Tartrate inhibits the DPP-4 enzyme in the body, preventing the degradation of incretin hormones. As a result, insulin secretion is increased, and blood sugar elevation is inhibited, aiding in blood glucose control.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Alogliptin Tartrate is similar to other DPP-4 inhibitors, but it differs in pharmacokinetic properties and tolerability, making it useful for patient-specific treatment.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

6 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Combined ingredients

Ingredients used together with this ingredient in combination products.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.